[
BioMarin Q4 2025 slides: 17% revenue growth amid ROCTAVIAN charges
[og_img]
https://www.investing.com/news/company-news/biomarin-q4-2025-slides-17-revenue-growth-amid-roctavian-charges-93CH-4520226
Investing.com
BioMarin Q4 2025 slides: 17% revenue growth amid ROCTAVIAN charges
Related articles




